If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you ...
A nebulizer is a medical device that turns liquid medicine into mist or aerosol that you inhale directly into your lungs. Medications used to treat respiratory conditions such as asthma, cystic ...
Inhalers and nebulizers are necessary when managing chronic obstructive pulmonary disease (COPD). Both are designed to deliver medication directly to the lungs, which helps in reducing symptoms, ...
A recent review revisited the question of whether inhalers and nebulizers have similar effectiveness to manage stable chronic obstructive pulmonary disease (COPD). A recent review revisited the ...
MIDLOTHIAN, Va., May 7, 2020 /PRNewswire/ -- This week, the first patients are enrolling in two phase 2 clinical trials for COVID-19 using Pulmotect's PUL-042, an inhaled immunomodulatory agent to ...
BiomX believes that it has fully addressed the FDA’s queries related to the third-party nebulizer used to deliver BX004, which are narrow in scope; an additional FDA request for limited technical ...
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used to deliver BX004; no concerns were raised in the clinical hold ...
The U.S. Food and Drug Administration placed a clinical hold on a study of BiomX's cystic fibrosis treatment in order to review data on the third-party nebulizer used to deliver the drug. Patient ...
Topical antiseptics such as hydrogen peroxide, iodine, or a combination of the two are not safe to inhale and not proven to treat respiratory infections, contrary to social media claims that breathing ...
Q3 2025 Management View Jonathan Solomon, CEO, stated that the third quarter of 2025 was an important period for BiomX, highlighting that "we began the quarter strongly with first patient dosing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results